Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.

AIDS research and human retroviruses - 1 Oct 2011

Parham Leda, de Rivera Ivette Lorenzana, Murillo Wendy, Naver Lars, Largaespada Natalia, Albert Jan, Karlsson Annika C

Abstract excerpt

Antiretroviral therapy has had a great impact on the prevention of mother-to-child transmission (MTCT) of HIV-1. However, development of drug resistance, which could be subsequently transmitted to the child, is a major concern. In Honduras and Belize the prevalence of drug resistance among HIV-1-infected children remains unknown. A total of 95 dried blood spot samples was obtained from HIV-1-infected, untreated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Nevirapine

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Reverse Transcriptase Inhibitors

Share to Zidovudine

Source

Identifiers

PMID: 21417948
DOI: 10.1089/AID.2010.0289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.PMID 21417948Read ↗

Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.Semantic proximity Read ↗

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.Semantic proximity Read ↗

Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil.Semantic proximity Read ↗

Prevalence of resistance mutations in HIV-1-Infected Hondurans at the beginning of the National Antiretroviral Therapy Program.Semantic proximity Read ↗

Prevalence of drug-resistant mutations in newly diagnosed drug-naïve HIV-1-infected individuals in a treatment site in the waterberg district, limpopo province.Semantic proximity Read ↗

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.Semantic proximity Read ↗

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.Semantic proximity Read ↗

Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.Semantic proximity Read ↗

Drug-resistant HIV-1 in Cuban children and their seropositive mothers.Semantic proximity Read ↗

High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in TogoSemantic proximity Read ↗

Determination of drug resistance and virus typology in HIV-1-positive pediatric patients in Istanbul, Turkey.Semantic proximity Read ↗

High Rate Of Antiretroviral Drug Resistance Mutations in HIV Type 1-Infected Senegalese Children in Virological Failure on First-Line Treatment According to the World Health Organization GuidelinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.